Vital Therapies Inc (VTL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Vital Therapies Inc (VTL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011445
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute liver failure by processing toxins and synthesizing proteins. Vital Therapies’s ELAD System contains immortal human liver-derived cells or VTL C3A cells that performs biochemical functions characteristic of human hepatocytes in in-vitro assays. Vital Therapies also provides programs for severe acute alcoholic hepatitis and alcohol induced liver decompensation, surgery-induced liver failure, fulminant liver failure, and chronic liver failure. It also conducts clinical trials. Vital Therapies is headquartered in San Diego, California, the US.

Vital Therapies Inc (VTL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vital Therapies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Vital Therapies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Vital Therapies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Vital Therapies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Vital Therapies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Vital Therapies Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Vital Therapies Raises US$12 Million In Venture Financing 10
Vital Therapies Raises US$2.5 Million In Venture Financing 11
Vital Therapies Secures USD4.35 Million in Venture Funding 12
Vital Therapies Secures US$22.6 Million In Financing 13
Equity Offering 14
Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$62.1 Million 14
Acquisition 16
Jilin Aodong Medicine Completes Acquisition Of 2% Stake In Vital Therapies For US$2 Million 16
Vital Therapies Inc – Key Competitors 17
Vital Therapies Inc – Key Employees 18
Vital Therapies Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Oct 25, 2017: Vital Therapies Announces Third Quarter 2017 Financial Results 20
Aug 03, 2017: Vital Therapies Announces Second Quarter 2017 Financial Results 22
May 09, 2017: Vital Therapies Announces First Quarter 2017 Financial Results 23
Mar 07, 2017: Vital Therapies Announces Fourth Quarter and Full Year 2016 Financial Results 24
Nov 03, 2016: Vital Therapies Announces Third Quarter Financial Results 25
Aug 02, 2016: Vital Therapies Announces Second Quarter Financial Results 26
May 09, 2016: Vital Therapies Announces First Quarter Financial Results 27
Mar 08, 2016: Vital Therapies Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update 28
Corporate Communications 30
Sep 06, 2017: Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors 30
Aug 15, 2016: Vital Therapies Announces Appointment of Former Receptos President and CEO Faheem Hasnain to Its Board of Directors 31
Legal and Regulatory 32
Dec 11, 2017: Vital Therapies Added to NASDAQ Biotechnology Index 32
Other Significant Developments 33
Sep 13, 2016: Vital Therapies Provides Corporate Update 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Vital Therapies Inc, Medical Equipment, Key Facts, 2016 2
Vital Therapies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Vital Therapies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Vital Therapies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Vital Therapies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Vital Therapies Inc, Deals By Market, 2011 to YTD 2017 8
Vital Therapies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Vital Therapies Raises US$12 Million In Venture Financing 10
Vital Therapies Raises US$2.5 Million In Venture Financing 11
Vital Therapies Secures USD4.35 Million in Venture Funding 12
Vital Therapies Secures US$22.6 Million In Financing 13
Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$62.1 Million 14
Jilin Aodong Medicine Completes Acquisition Of 2% Stake In Vital Therapies For US$2 Million 16
Vital Therapies Inc, Key Competitors 17
Vital Therapies Inc, Key Employees 18
Vital Therapies Inc, Subsidiaries 19

★海外企業調査レポート[Vital Therapies Inc (VTL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • United Therapeutics Corp (UTHR):医療機器:M&Aディール及び事業提携情報
    Summary United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues including Remodulin (tre …
  • Ingka Holding B.V.:企業の戦略・SWOT・財務情報
    Ingka Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Ingka Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nipro Corp (8086):医療機器:M&Aディール及び事業提携情報
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary …
  • PerkinElmer Inc (PKI):医療機器:M&Aディール及び事業提携情報
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company’s major products include cytogenetics reagen …
  • Groupe Sodiaal:戦略・SWOT・企業財務分析
    Groupe Sodiaal - Strategy, SWOT and Corporate Finance Report Summary Groupe Sodiaal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ABC Supply Co. Inc.:企業の戦略・SWOT・財務情報
    ABC Supply Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary ABC Supply Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cermaq Group AS:企業の戦略的SWOT分析
    Cermaq Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Quark Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Quark Pharmaceuticals Inc (Quark), a subsidiary of SBI Biotech Co Ltd, is a clinical-stage pharmaceutical company in the development of novel RNAi-based therapeutics. It offers under development products which include PF-655, a synthetic siRNA which is used for the treatment of diabetic macu …
  • Lundin Petroleum AB (LUPE):企業の財務・戦略的SWOT分析
    Summary Lundin Petroleum AB (Lundin Petroleum) is an independent oil and gas exploration and production company that acquires, explores, develops and produces oil and gas properties in Norway. The company identifies and matures exploration targets, drill exploration wells, appraise discoveries, and …
  • Teradyne Inc (TER):企業の財務・戦略的SWOT分析
    Teradyne Inc (TER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Sunnybrook Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Sunnybrook Research Institute (SRI) an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate and doctoral degree programs. It provides research platforms for biological sciences, evaluative clinical sciences and physical …
  • Human Longevity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Human Longevity Inc (HLI) is a genomics-based technology company that develops sequenced genomes and phenotypic database. The company’s discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomarker and comp …
  • Iliad S.A. (ILD):企業の財務・戦略的SWOT分析
    Iliad S.A. (ILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kimball Electronics Inc (KE):企業の財務・戦略的SWOT分析
    Kimball Electronics Inc (KE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Fresenius Kidney Care:医療機器:M&Aディール及び事業提携情報
    Summary Fresenius Kidney Care (FMCNA), formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical …
  • Taconic Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Taconic Biosciences Inc (Taconic), formerly Taconic Farms Inc is a research model provider that offers animal health models and laboratory services. The company’s products include taconic transgenic models, emerging models, knockout repository, GEM collection, traditional models, diet induce …
  • Sky plc (SKY):企業の財務・戦略的SWOT分析
    Sky plc (SKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Genoptix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genoptix Inc (Genoptix) is a hematopathology center which provides oncology diagnostics and informatics services specializing in hematology and solid tumors. The center offers biopharma and healthcare laboratory, discovery, drug development, care and cost development, and patient services. G …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • ViraTherapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ViraTherapeutics GmbH (ViraTherapeutics) is a biotechnology company that develops high potential anti-cancer therapeutics based on cancer-destroying oncolytic viruses. The company provides VSV-GP which is a proprietary oncolytic virus platform, which helps in destroying cancer cells and is u …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆